# An integrative ultrastructural and transcriptomic analysis of host–pathogen interactions with human brain microvascular endothelial cells during cryptococcal infection: a preliminary study

**Authors:** Priya Krishnan, Gautham Arunachal Udupi, Rashmi Santhoshkumar, Manjunatha. M. V., Veena Kumari H. B., Netravathi, Nagarathna S.

PMC · DOI: 10.3389/fcimb.2026.1735570 · Frontiers in Cellular and Infection Microbiology · 2026-02-09

## TL;DR

This study explores how brain endothelial cells respond to Cryptococcus infection using electron microscopy and RNA sequencing to reveal structural and genetic changes.

## Contribution

The study integrates ultrastructural and transcriptomic data to reveal conserved host-pathogen interactions at the blood-brain barrier during cryptococcal infection.

## Key findings

- Infected HBMECs show ultrastructural changes like membrane ruffling and mitochondrial alterations.
- Transcriptomic analysis reveals activation of immune signaling pathways in response to Cryptococcus.
- Clinical and environmental isolates elicit similar host responses, suggesting conserved pathogenic mechanisms.

## Abstract

In humans, Cryptococcus neoformans and Cryptococcus gattii species complexes are the leading cause of fungal meningitis globally. To establish CNS infection, Cryptococcus must breach the BBB, primarily comprised of specialized brain microvascular endothelial cells (BMECs), which is the prerequisite for cryptococci to invade the brain. Despite its clinical impact, the mechanisms underlying host–pathogen interaction at the BBB particularly involving environmental isolates remain under-characterized.

This study aimed to investigate the cyto-morphological and transcriptomic responses of HBMECs to infection by clinical and environmental Cryptococcus isolates using a dual approach—ultrastructural electron microscopy and high-throughput dual RNA-Seq.

HBMECs were infected in vitro with molecularly typed clinical and environmental isolates of C. neoformans and C. gattii at two infection time points (4 hpi and 18 hpi). Transmission electron microscopy was used to visualize host cell ultrastructural alterations, while dual RNA-Seq was performed to assess differential gene expression in both host and pathogen.

TEM revealed extensive ultrastructural changes in infected HBMECs, including membrane ruffling, increased microvilli, mitochondrial alterations, ER dilation, Golgi fragmentation, nuclear deformation, and autophagosome formation. Transcriptomic profiling demonstrated functional enrichment of several critical cryptococcal virulence-associated genes linked to immune evasion and stress adaptation including various immune signaling pathways elicited by the HBMECs as a counter measure to the cryptococcal invasion.

Clinical and environmental Cryptococcus isolates exhibit comparable invasive potential and elicit similar host endothelial responses with consistent effects observed across all isolates and time points. This integrative study combining ultrastructural and transcriptomic analyses highlights conserved host-pathogen interactions at the BBB, identifies potential molecular targets for antifungal therapy and underscores the pathogenic relevance of environmental reservoirs in cryptococcal meningitis. cryptococcal meningitis, blood-brain barrier, invasion, transmission electron microscopy, Dual RNASeq, differential gene expression, host-pathogen interaction, HBMECs, ultrastructural alterations.

## Linked entities

- **Diseases:** fungal meningitis (MONDO:0006764), cryptococcal meningitis (MONDO:0005723)
- **Species:** Cryptococcus neoformans (taxon 5207), Cryptococcus gattii (taxon 37769), Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** ITGB8 (integrin subunit beta 8) [NCBI Gene 3696], TRIM22 (tripartite motif containing 22) [NCBI Gene 10346] {aka GPSTAF50, RNF94, STAF50}, SLC2A1 (solute carrier family 2 member 1) [NCBI Gene 6513] {aka CSE, DYT17, DYT18, DYT9, EIG12, GLUT}, Hes1 (hes family bHLH transcription factor 1) [NCBI Gene 15205] {aka Hry, bHLHb39}, HSPB6 (heat shock protein family B (small) member 6) [NCBI Gene 126393] {aka HEL55, Hsp20, PPP1R91}, BBC3 (BCL2 binding component 3) [NCBI Gene 27113] {aka JFY-1, JFY1, PUMA}, ADAMTS13 (ADAM metallopeptidase with thrombospondin type 1 motif 13) [NCBI Gene 11093] {aka ADAM-TS13, ADAMTS-13, C9orf8, VWFCP, vWF-CP}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, DOCK8 (dedicator of cytokinesis 8) [NCBI Gene 81704] {aka HEL-205, HIES2, MRD2, ZIR8}, PCSK9 (proprotein convertase subtilisin/kexin type 9) [NCBI Gene 255738] {aka FH3, FHCL3, HCHOLA3, LDLCQ1, NARC-1, NARC1}, AQP1 (aquaporin 1 (Colton blood group)) [NCBI Gene 358] {aka AQP-CHIP, CHIP28, CO}, NUPR1 (nuclear protein 1, transcriptional regulator) [NCBI Gene 26471] {aka COM1, P8}, TP53INP1 (tumor protein p53 inducible nuclear protein 1) [NCBI Gene 94241] {aka SIP, TP53DINP1, TP53INP1A, TP53INP1B, Teap, p53DINP1}, Creb3l3 (cAMP responsive element binding protein 3-like 3) [NCBI Gene 208677] {aka CREB-H, D10Bur1e}, Fosb (Fos B proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 14282], VCAM1 (vascular cell adhesion molecule 1) [NCBI Gene 7412] {aka CD106, INCAM-100}, CYP1B1 (cytochrome P450 family 1 subfamily B member 1) [NCBI Gene 1545] {aka ASGD6, CP1B, CYPIB1, GLC3A, P4501B1}, IL34 (interleukin 34) [NCBI Gene 146433] {aka C16orf77, IL-34}, TNFSF13 (TNF superfamily member 13) [NCBI Gene 8741] {aka APRIL, CD256, TALL-2, TALL2, TNLG7B, TRDL-1}, TLR3 (toll like receptor 3) [NCBI Gene 7098] {aka CD283, IIAE2, IMD83}, PTGIS (prostaglandin I2 synthase) [NCBI Gene 5740] {aka CYP8, CYP8A1, PGIS, PTGI}, Fos (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 14281] {aka D12Rfj1, c-fos, cFos}, BACE1 (beta-secretase 1) [NCBI Gene 23621] {aka ASP2, BACE, HSPC104}, TRPV4 (transient receptor potential cation channel subfamily V member 4) [NCBI Gene 59341] {aka BCYM3, CMT2C, HMSN2C, OTRPC4, SMAL, SPSMA}, IFITM2 (interferon induced transmembrane protein 2) [NCBI Gene 10581] {aka 1-8D, DSPA2c}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, TRIB3 (tribbles pseudokinase 3) [NCBI Gene 57761] {aka C20orf97, NIPK, SINK, SKIP3, TRB3}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, TNFRSF14 (TNF receptor superfamily member 14) [NCBI Gene 8764] {aka ATAR, CD270, HVEA, HVEM, LIGHTR, TR2}, CCL5 (C-C motif chemokine ligand 5) [NCBI Gene 6352] {aka D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228}, Dpf3 (double PHD fingers 3) [NCBI Gene 70127] {aka 2810403B03Rik, 6530402L11Rik, BAF45C, CERD4, Gm18872, cer-d4}, DDIT4 (DNA damage inducible transcript 4) [NCBI Gene 54541] {aka Dig2, REDD-1, REDD1}, FBN1 (fibrillin 1) [NCBI Gene 2200] {aka ACMICD, ECTOL1, FBN, GPHYSD2, MASS, MFLS}, ADM2 (adrenomedullin 2) [NCBI Gene 79924] {aka AM2, dJ579N16.4}, SLC7A11 (solute carrier family 7 member 11) [NCBI Gene 23657] {aka CCBR1, xCT}, DDIT3 (DNA damage inducible transcript 3) [NCBI Gene 1649] {aka AltDDIT3, C/EBPzeta, CEBPZ, CHOP, CHOP-10, CHOP10}, RAPGEF3 (Rap guanine nucleotide exchange factor 3) [NCBI Gene 10411] {aka CAMP-GEFI, EPAC, EPAC1, HSU79275, bcm910}, ITGB3 (integrin subunit beta 3) [NCBI Gene 3690] {aka BDPLT16, BDPLT2, BDPLT24, CD61, FMAIT1, GP3A}, EMILIN2 (elastin microfibril interfacer 2) [NCBI Gene 84034] {aka EMILIN-2, FOAP-10}, CYP1A1 (cytochrome P450 family 1 subfamily A member 1) [NCBI Gene 1543] {aka AHH, CP11, CYP1, CYPIA1, P1-450, P450-C}, VTN (vitronectin) [NCBI Gene 7448] {aka V75, VN, VNT}, RAB39B (RAB39B, member RAS oncogene family) [NCBI Gene 116442] {aka BGMR, MRX72, WSMN, WSN, XLID72}, GRIK5 (glutamate ionotropic receptor kainate type subunit 5) [NCBI Gene 2901] {aka EAA2, GRIK2, GluK5, KA2}
- **Diseases:** fungal meningitis (MESH:D016921), CNS infection (MESH:D002494), fungal (MESH:D009181), infectious diseases (MESH:D003141), Infection (MESH:D007239), cryptococcal (MESH:D016919), osteoclast (MESH:D001862), C.neoformans infection (MESH:D003453), hypoxia (MESH:D000860), pulmonary infection (MESH:D012141), inflammation (MESH:D007249), PK (MESH:C564858), mitochondrial dysfunction (MESH:D028361)
- **Chemicals:** propylene oxide (MESH:C009068), CO2 (MESH:D002245), glutathione (MESH:D005978), SYBR Green (MESH:C098022), lipid (MESH:D008055), paraformaldehyde (MESH:C003043), sterol (MESH:D013261), agarose (MESH:D012685), melanin (MESH:D008543), glutaraldehyde (MESH:D005976), PBS (MESH:D007854), Inositol (MESH:D007294), ROS (MESH:D017382), calcium (MESH:D002118), Minimum Essential media (-), amphotericin B (MESH:D000666), ergosterol (MESH:D004875), uranyl acetate (MESH:C005460), carbohydrate (MESH:D002241), free radicals (MESH:D005609), peptides (MESH:D010455), iron (MESH:D007501), amphetamine (MESH:D000661), copper (MESH:D003300), ethanol (MESH:D000431), acids (MESH:D000143), Osmium tetroxide (MESH:D009993), histidine (MESH:D006639), nitrogen (MESH:D009584), araldite (MESH:C005752), Triton X-100 (MESH:D017830)
- **Species:** Eucalyptus camaldulensis (Murray red gum, species) [taxon 34316], Homo sapiens (human, species) [taxon 9606], Cryptococcus neoformans (Cryptococcus neoformans serotype A, species) [taxon 5207], Chlamydia trachomatis (species) [taxon 813], Orf virus (no rank) [taxon 10258], Candida albicans (species) [taxon 5476], Hepatitis C virus [taxon 11103], Human rhinovirus sp. (species) [taxon 169066], Rickettsia rickettsii (species) [taxon 783], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932]
- **Mutations:** A4770W, A4480W
- **Cell lines:** HBMEC — Homo sapiens (Human), Transformed cell line (CVCL_0307)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12926436/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12926436/full.md

## References

80 references — full list in the complete paper: https://tomesphere.com/paper/PMC12926436/full.md

---
Source: https://tomesphere.com/paper/PMC12926436